← Eichor
Condition: Rivaroxaban Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Rivaroxaban

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
Phase 4 · 1 location(s) · Zunyi Medical College · NCT06013020ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
Phase 3 · 6 location(s) · Prof. Stavros Konstantinides, MD · NCT06611319AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positiv
Phase 3 · 42 location(s) · University Hospital, Brest · NCT05198960Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization
Phase 4 · 1 location(s) · AHEPA University Hospital · NCT06812455Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
Phase 1 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04874428Phase I Study of MT1011 Injection in Healthy Subjects
Phase 1 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT07024160Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149Excretion of Rivaroxaban in Human Breast Milk
Phase 1 · 1 location(s) · Thomas Jefferson University · NCT06831474Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrill
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT06187311A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombo
Phase 2/Phase 3 · 2 location(s) · Ottawa Hospital Research Institute · NCT06965998Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Phase 4 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06486792Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT05643651Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients
Phase 3 · 2 location(s) · University Hospital, Tours · NCT05410275Rivaroxaban in Idiopathic Membranous Nephropathy
Phase 4 · 1 location(s) · Beijing Friendship Hospital · NCT07404436Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NA · 1 location(s) · Scott C. Woller, MD · NCT06232551STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for O
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06901466Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
NA · 1 location(s) · Alexandria University · NCT06689241Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Phase N/A · 33 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06556446Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06108414Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant
NA · 14 location(s) · McMaster University · NCT06957366Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population
Phase N/A · 1 location(s) · Azienda Ospedaliero, Universitaria Ospedali Riuniti · NCT06371170Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT06978439VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
NA · 1 location(s) · Medical University of Gdansk · NCT07270263Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06531122Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
Phase N/A · 1 location(s) · Xuanwu Hospital, Beijing · NCT06947707LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atri
Phase 3 · 17 location(s) · Rennes University Hospital · NCT07202897Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
Phase N/A · 1 location(s) · Hieu Trung Dinh · NCT07083609VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/Phase 3 · 1 location(s) · Ottawa Hospital Research Institute · NCT05920343Registry of Patients Prescribed Anticoagulation
Phase N/A · 1 location(s) · Mayo Clinic · NCT03504007
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.